ASI-MV Connect is a comprehensive suite of evidence-based behavioral health assessment tools developed with funding from the National Institute on Drug Abuse (NIDA). Designed for healthcare providers, it streamlines client intake and evaluation processes through self-administered, audio-assisted assessments that can be completed remotely or in-office. The platform supports treatment planning, risk stratification, and outcome measurement across multiple domains of a client’s life.

Features

• Behavioral Health Assessment Suite: Includes ASI-MV, BHI-MV, and CHAT tools for adolescents (13–18) and adults (18+).
• Client Self-Administration: Assessments can be completed independently by clients with audio support, either remotely or on-site.
• Automated Scoring & Reporting: Immediate access to scores and summary reports with severity ratings and composite scores across seven life domains: medical, employment, alcohol, drug, legal, family/social, and psychological.
• Narrative Report & Worksheets: Clinicians can add impressions and use worksheets for treatment planning, placement, referrals, and outcome tracking.
• Account Management: Supports unlimited users and locations with centralized access control.
• Pain Management Tools: Includes Pain and Functioning Index, SOAPP-8, and COMM-9 for assessing opioid therapy risks and benefits.
• Validated Instruments: All tools are tested and validated for clinical reliability and effectiveness.

Benefits

• Improved Workflow Efficiency: Automates intake and scoring, allowing providers to focus on treatment rather than administrative tasks.
• Enhanced Patient Outcomes: Standardized assessments help identify issues early and guide effective treatment strategies.
• Scalable Across Organizations: Suitable for clinics, hospitals, and behavioral health networks with multi-location support.
• Remote Accessibility: Enables clients to complete assessments from home, improving compliance and convenience.
• Comprehensive Risk Stratification: Identifies potential substance abuse and opioid misuse risks before therapy begins.
• Cost-Effective: Subscription packages offer assessments at $10 or less per use for bulk purchases.